Physician profile
Michael Napolitano
NPI 1871238907
$674.85
in general payments reported to CMS, 2019-2025
13 companies · $432 in 2025
The $432 reported for 2025 was more than what 77% of Integrative Medicine providers received nationally (typical 2025 total: $57.65).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $243 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $149.04 | 2024-2025 | Airsupra, Breztri |
| Atricure, INC. | $145.94 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Novo Nordisk INC | $76.65 | 2025 | Rybelsus, Ozempic |
| Lundbeck LLC | $58.32 | 2024-2025 | Rexulti |
| Glaxosmithkline, LLC. | $42.50 | 2024 | Trelegy Ellipta, Arexvy |
| Kowa Pharmaceuticals America, INC. | $40.85 | 2024-2025 | Zoryve |
| Lilly USA, LLC | $39.24 | 2024 | Mounjaro, Zepbound |
| Abbvie INC. | $25.65 | 2025 | |
| Abbott Laboratories | $22.41 | 2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $21.88 | 2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $19.85 | 2025 | Sunosi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.35 | 2024 | Xifaxan |
| Pfizer INC. | $14.17 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Napolitano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.